AU Patent

AU2011273549B2 — Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution

Assigned to Laboratoires Thea SAS · Expires 2013-06-27 · 13y expired

What this patent protects

The present invention relates to an ophthalmic solution which comprises: - at least one prostaglandin; - a solubilizing agent; - a carbomer gelling agent; - a carbomer-polymerization-inhibiting agent; - a co-gelling/co-solubilizing agent.

USPTO Abstract

The present invention relates to an ophthalmic solution which comprises: - at least one prostaglandin; - a solubilizing agent; - a carbomer gelling agent; - a carbomer-polymerization-inhibiting agent; - a co-gelling/co-solubilizing agent.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011273549B2
Jurisdiction
AU
Classification
—
Expires
2013-06-27
Drug substance claim
No
Drug product claim
No
Assignee
Laboratoires Thea SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.